Martinsried, Germany, March 22, 2010 / b3c newswire / - ChromoTek, a company specializing in bioimaging reagents, has launched the bioimaging tools RFP-Trap® and GFP-Booster. RFP-Trap® is used to identify and pull down interaction partners of proteins tagged with RFP (red fluorescent protein) and GFP-Booster restores or increases the GFP (green fluorescent protein) signal in super-resolution microscopy.

RFP-Trap® is a versatile tool for biochemical and cell biological analysis of RFP-tagged fusion proteins in pull down assays (a frequently used in vitro method used to determine physical interaction between two or more proteins). Generally, pull down experiments have been performed with antibodies. But as they are bulky molecules they tend to disintegrate during the purification process, making it difficult to further analyze the proteins of interest by mass spectrometry or Western blot. ChromoTek has found a way to circumvent this problem by using small recombinant binding molecules, so called nanotraps instead of antibodies. Nanotraps bind their targets with similar efficiency but are only a tenth of the size of conventional antibodies and much more stable, thus allowing to effectively reduce background in pull down experiments.

Fig. 1: The RFP-Trap® pulls down all major variants of RFP (mCherry, mOrange) from cell extracts with minimal background

(For a high resolution picture please right-click the image and select "Save Target As...")

GFP is a powerful tool to study protein localization and dynamics in living cells. However, the photo stability and the quantum efficiency of GFP are not sufficient for super-resolution microscopy (e.g. 3D-SIM or STED) of fixed samples from cells expressing GFP fusion proteins to visualize specific structures. Furthermore, many currently used procedures for FISH or BrdU detection lead to disruption of the GFP signal. ChromoTek now has developed a GFP booster consisting of a chemical fluorescent dye that is covalently attached to a GFP Nanotrap thus providing high fluorescence intensities and signal-to-noise ratios.

Fig. 2: Enhancement of GFP signal with GFP-Booster after EdU-Click-iT™ treatment. EdU-Click-iT™ treament leads to disruption of GFP signal. GFP-Booster labels GFP fusion proteins and thus reactivates and boosts the fluorescence.

(For a high resolution picture please right-click the image and select "Save Target As...")
 

Fluorescent proteins are indispensible markers that have enabled scientists to visualize molecular interactions within cells. The two most popular markers, GFP and RFP, are used in thousands of labs worldwide as tags for cellular proteins. GFP has proved to be so important for modern biomedical research that it earned its discoverers the 2008 Nobel prize.

Visit us at analytica 2010, Hall A3, Booth 261/360 

About ChromoTek - www.chromotek.com
ChromoTek is a biotech company specialising in molecular tools for bioimaging and proteome analysis. ChromoTek’s lead product, the GFP-Trap®, is used for immunoprecipitation (IP, coIP) and/or affinity purification of GFP-tagged proteins. The company also develops vectors and cell lines for high content analysis (HCA) of important cellular markers, with a primary focus on cell cycle, apoptosis and metabolism.
ChromoTek was founded in 2008 and is located in Martinsried, Germany. The company works closely together with the Center for Integrated Protein Science Munich at the Biocenter of the Ludwig-Maximilian-University Munich. ChromoTek currently markets its products in four continents (Europe, North America, Asia and Australia). For more information about ChromoTek, please visit http://www.chromotek.com.

Contact
Dr. Ulrich Rothbauer
+49-89-2352-6927
u.rothbauer@chromotek.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.